Improvements in Survival and Disparities for Advanced-Stage Laryngeal Cancer

被引:23
|
作者
LeBlanc, Blake Joseph [1 ]
Shi, Runhua [2 ]
Mehta, Vikas [1 ]
Mills, Glenn [3 ]
Ampil, Federico [4 ]
Nathan, Cherie-Ann O. [1 ]
机构
[1] Louisiana State Univ Hlth Shreveport, Dept Otolaryngol Head & Neck Surg, Shreveport, LA USA
[2] Louisiana State Univ Hlth Shreveport, Dept Med, Shreveport, LA USA
[3] Louisiana State Univ Hlth Shreveport, Dept Oncol, Shreveport, LA USA
[4] Louisiana State Univ Hlth Shreveport, Dept Radiat Oncol, Shreveport, LA USA
关键词
SQUAMOUS-CELL CARCINOMA; ORGAN PRESERVATION; CARTILAGE INVASION; TRENDS; CHEMOTHERAPY; STRATEGIES; SURGERY; CARE;
D O I
10.1001/jamaoto.2014.2998
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
IMPORTANCE Laryngeal cancer survival rates have declined over the past 2 decades. Primary surgical therapy may increase survival rates in advanced-stage tumors. OBJECTIVE To compare survival outcomes for initial surgical treatment of advanced-stage primary tumors in the Louisiana health system with outcomes in the National Cancer Database (NCDB). DESIGN, SETTING, AND PARTICIPANTS Retrospective analysis was conducted at an academic tertiary referral hospital. Patients diagnosed as having laryngeal carcinoma between 1998 and 2007 were identified via a tumor registry. Louisiana State University Health-Shreveport (LSU Health) data and national data from 2000 to 2010 were obtained from the NCDB of the American College of Surgeons. INTERVENTIONS Treatment of laryngeal cancer. MAIN OUTCOMES AND MEASURES Age, sex, race/ethnicity, socioeconomic status, laryngeal subsite, stage, primary treatment modality, and observed survival were analyzed and compared. RESULTS A total of 165 patients treated at LSU Health met the inclusion criteria. One hundred seventeen (70.91%) presented with advanced-stage (III/IV) disease, compared with 46.67% nationwide (P < .01). For stage IV disease our 5-year survival rate was 55.54%(95% CI, 43.35%-66.11%) compared with 31.60% (95% CI, 30.40%-32.90%) nationally (P < .05). Our proportion of uninsured patients was 23.73% vs 5.05% of patients nationally (P < .001), and our patients traveled further distances for care with 60.47% traveling 50 miles or more, compared with 15.87% nationally (P < .001). Sixty-four of the patients with advanced-stage disease (54.70%) underwent primary surgical therapy to include total laryngectomy. Data from the NCDB indicate that the rate of laryngectomy declined from 40% to 60% in the 1980s to 32% in 2007. CONCLUSIONS AND RELEVANCE Louisiana State University Health-Shreveport treated more uninsured patients with advanced-stage laryngeal cancer compared with national data but demonstrated higher survival rates for those with advanced-stage disease. The results also demonstrate that we have continued a high rate of primary surgical therapy for advanced-stage disease, despite the national trend toward organ preservation. We believe that upfront laryngectomy may explain our higher survival rates for advanced-stage laryngeal cancer.
引用
收藏
页码:169 / 173
页数:5
相关论文
共 50 条
  • [41] Systematic Lymphadenectomy Improves Survival in Patients with Advanced-Stage Primary Fallopian Tube Cancer
    Kim, Yong Man
    Jung, Min Hyung
    Kim, Dae-Yeon
    Kim, Jong Hyeok
    Kim, Young Tak
    Nam, Joo Hyun
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 218 (01): : 5 - 9
  • [42] Adjuvant Treatment of Advanced-stage Endometrial Cancer
    Lee, Nita Karnik
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2011, 54 (02): : 256 - 265
  • [43] Can advanced-stage ovarian cancer be cured?
    Narod, Steven
    NATURE REVIEWS CLINICAL ONCOLOGY, 2016, 13 (04) : 255 - 261
  • [44] Improvements in Hospice Utilization Among Patients With Advanced-Stage Lung Cancer in an Integrated Health Care System
    Sullivan, Donald R.
    Ganzini, Linda
    Lapidus, Jodi A.
    Hansen, Lissi
    Carney, Patricia A.
    Osborne, Molly L.
    Fromme, Erik K.
    Izumi, Seiko
    Slatore, Christopher G.
    CANCER, 2018, 124 (02) : 426 - 433
  • [45] Survival analysis of young patients with advanced-stage ovarian and primary peritoneal cancer.
    Chuang, L. T.
    Romano, S.
    Dottino, P. R.
    Rahaman, J.
    Lerner, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [46] Perception of survival/laryngeal preservation trade-off in advanced T-stage laryngeal cancer
    Laccourreye, O.
    Mirghani, H.
    Guiquerro, S.
    Quer, M.
    Giraud, P.
    EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES, 2023, 140 (02) : 77 - 80
  • [47] Advanced-stage pancreatic cancer: therapy options
    Jens Werner
    Stephanie E. Combs
    Christoph Springfeld
    Werner Hartwig
    Thilo Hackert
    Markus W. Büchler
    Nature Reviews Clinical Oncology, 2013, 10 : 323 - 333
  • [48] Drug Therapy for Advanced-Stage Liver Cancer
    Peck-Radosavljevic, Markus
    LIVER CANCER, 2014, 3 (02) : 125 - 131
  • [49] Management of Advanced-Stage and Recurrent Endometrial Cancer
    Ray, Mandira
    Fleming, Gini
    SEMINARS IN ONCOLOGY, 2009, 36 (02) : 145 - 154
  • [50] Survival Outcomes in Advanced Laryngeal Cancer
    Megwalu, Uchechukwu C.
    Sikora, Andrew G.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2014, 140 (09) : 855 - 860